Preparation, characterization, and in vitro release of folic acid-conjugated chitosan nanoparticles loaded with methotrexate for targeted delivery

Abstract

To reduce the toxicity of methotrexate (MTX) and increase the targeting of nanoparticles, the MTX-loaded chitosan (CS) covalently bonded with folic acid (FA) nanoparticles were prepared, and sodium tripolyphosphate was used as the cross-linking agent. FA was successfully conjugated to CS confirmed by 1 H-NMR and Fourier transform infrared spectrometer (FT-IR). The prepared FA-CS nanoparticles were characterized by FT-IR spectroscopy to confirm the cross-linking reaction between FA-CS and cross-linking agent. X-ray diffraction was performed to reveal the crystalline nature of the drug after encapsulation. The average diameters of the nanoparticles ranged from 293.9 ± 24.2 to 401.5 ± 20.4 nm with a narrow particle size distribution. In vitro release pattern in phosphate buffer saline (pH 6.8) indicated that the characteristics of the MTX-loaded nanoparticles appeared to have an initial burst effect and followed by a slow, sustained drug release. FA or low molecular weight FA conjugate fragments were also released from the nanoparticles, which might have potential to reduce toxic effects of MTX within the body.

Dextran-Curcumin Nanoparticles as a Methotrexate Delivery Vehicle: A Step Forward in Breast Cancer Combination Therapy

“…The results clearly proved the ability of DC to control the MTX release over time, and are consistent with literature data evaluating the drug delivery performance of nanoparticle systems [34,35].…”

Synthesis and characterization of Zinc/Chitosan-Folic acid complex

“…8 ), and the polydispersity index (PDI) was 0.29 ± 0.02. The PDI value below 0.300 indicated that the distribution of particle size was in a narrow range ( Ji et al., 2012 ). The zeta potential (ZP) measurements were carried out for chitosan, ZnS/Chitosan, and ZnS/Chitosan- Folic acid samples dissolved in 1% acetic acid.…”

Actively Targeted and Redox Responsive Delivery of Anticancer Drug by Chitosan Nanoparticles

“…Moreover, CHT is considered a natural anticancer polysaccharide. Many in vitro and in vivo studies were published thanks to the application of this polymer for the design of anticancer tools [5][6][7], but their efficacy is restricted due to the low efficiency of specific targeting [8]. However, the presence of reactive functional groups gives huge opportunities for chemical modifications with a wide range of molecules in order to improve its targeting tumor ability.…”